Latest Articles
Aprea reports second partial response in endometrial cancer trial By Investing.com - Investing.com South Africa
Aprea reports second partial response in endometrial cancer trial By Investing.com Investing.com South Africa
Published: Feb. 19, 2026, 12:54 a.m.
Aprea reports second partial response in endometrial cancer trial - Investing.com Nigeria
Aprea reports second partial response in endometrial cancer trial Investing.com Nigeria
Published: Feb. 18, 2026, 11:46 p.m.
Ballymun public meeting aims to break silence on PMDD and endometriosis - MSN
Ballymun public meeting aims to break silence on PMDD and endometriosis MSN
Published: Feb. 18, 2026, 9:35 p.m.
Endometriosis: Search continues for key staff for Cork regional centre - MSN
Endometriosis: Search continues for key staff for Cork regional centre MSN
Published: Feb. 18, 2026, 9:25 p.m.
Body fat percentage associated with endometriosis severity in cross-sectional analysis - Contemporary OB/GYN
Body fat percentage associated with endometriosis severity in cross-sectional analysis Contemporary OB/GYN
Published: Feb. 18, 2026, 8:38 p.m.
Doctor addresses endometriosis myths and treatment options - WTOC
Doctor addresses endometriosis myths and treatment options WTOC
Published: Feb. 18, 2026, 5:38 p.m.
Ballymun public meeting aims to break silence on PMDD and endometriosis - Dublin Live
Ballymun public meeting aims to break silence on PMDD and endometriosis Dublin Live
Published: Feb. 18, 2026, 4:28 p.m.
Behind the Harry Reich Award at EndoFound’s Annual Medical Conference - Endometriosis Foundation of America
Behind the Harry Reich Award at EndoFound’s Annual Medical Conference Endometriosis Foundation of America
Published: Feb. 18, 2026, 4:10 p.m.
Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider
Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer Femtech Insider
Published: Feb. 18, 2026, 3:28 p.m.
Sensei Biotherapeutics Acquires Faeth Therapeutics in $200M Deal, Advancing Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider
Sensei Biotherapeutics Acquires Faeth Therapeutics in $200M Deal, Advancing Multi-Node Cancer Therapy for Endometrial and Breast Cancer Femtech Insider
Published: Feb. 18, 2026, 3:28 p.m.
Link copied to clipboard!